These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2664885)

  • 1. Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders.
    Wahlestedt C; Ekman R; Widerlöv E
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):31-54. PubMed ID: 2664885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses.
    Heilig M; Widerlöv E
    Acta Psychiatr Scand; 1990 Aug; 82(2):95-114. PubMed ID: 2173355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The putative neuroprotective role of neuropeptide Y in the central nervous system.
    Silva AP; Xapelli S; Grouzmann E; Cavadas C
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):331-47. PubMed ID: 16101553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y and sleep.
    Dyzma M; Boudjeltia KZ; Faraut B; Kerkhofs M
    Sleep Med Rev; 2010 Jun; 14(3):161-5. PubMed ID: 20122859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y (NPY) and depression: from animal studies to the human condition.
    Redrobe JP; Dumont Y; Quirion R
    Life Sci; 2002 Nov; 71(25):2921-37. PubMed ID: 12384178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y and limbic seizures.
    Baraban SC
    Rev Neurosci; 1998; 9(2):117-28. PubMed ID: 9711903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of neuropeptide Y (NPY) in psychiatry.
    Eaton K; Sallee FR; Sah R
    Curr Top Med Chem; 2007; 7(17):1645-59. PubMed ID: 17979774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role of neuropeptide Y in depression and stress.
    Morales-Medina JC; Dumont Y; Quirion R
    Brain Res; 2010 Feb; 1314():194-205. PubMed ID: 19782662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin and NPY, two peptides with multiple putative roles in the nervous system.
    Hökfelt T; Broberger C; Diez M; Xu ZQ; Shi T; Kopp J; Zhang X; Holmberg K; Landry M; Koistinaho J
    Horm Metab Res; 1999 May; 31(5):330-4. PubMed ID: 10422730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
    Duarte-Neves J; Pereira de Almeida L; Cavadas C
    Neurobiol Dis; 2016 Nov; 95():210-24. PubMed ID: 27461050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and clinical studies with somatostatin related to the central nervous system.
    Vécsei L; Widerlöv E
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):473-502. PubMed ID: 1978375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPY and cohorts in human disease. Proceedings of the 8th International NPY Meeting. April 22-26, 2006. St. Petersburg, Florida, USA.
    Peptides; 2007 Feb; 28(2):197-483. PubMed ID: 17207556
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuropeptide Y and autonomic nervous system].
    Nozdrachev AD; Masliukov PM
    Zh Evol Biokhim Fiziol; 2011; 47(2):105-12. PubMed ID: 21598694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?
    Obuchowicz E; Krysiak R; Herman ZS
    Neurosci Biobehav Rev; 2004 Oct; 28(6):595-610. PubMed ID: 15527865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.
    Scharfman HE; MacLusky NJ
    Front Neuroendocrinol; 2006 Dec; 27(4):415-35. PubMed ID: 17055560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropeptide Y: psychopharmacological and clinical aspects].
    Nakagawara M; Sato Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):117-27. PubMed ID: 7941776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system pharmacology of neuropeptide Y.
    Wettstein JG; Earley B; Junien JL
    Pharmacol Ther; 1995 Mar; 65(3):397-414. PubMed ID: 7644568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin in neuropsychiatric disorders.
    Rubinow DR; Davis CL; Post RM
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S137-55. PubMed ID: 2907936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
    dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
    Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
    Dumont Y; Chabot JG; Quirion R
    Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.